QQQ   444.01 (-0.18%)
AAPL   171.48 (-1.06%)
MSFT   420.72 (-0.17%)
META   485.58 (-1.68%)
GOOGL   150.93 (+0.04%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.14%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
QQQ   444.01 (-0.18%)
AAPL   171.48 (-1.06%)
MSFT   420.72 (-0.17%)
META   485.58 (-1.68%)
GOOGL   150.93 (+0.04%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.14%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
QQQ   444.01 (-0.18%)
AAPL   171.48 (-1.06%)
MSFT   420.72 (-0.17%)
META   485.58 (-1.68%)
GOOGL   150.93 (+0.04%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.14%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
QQQ   444.01 (-0.18%)
AAPL   171.48 (-1.06%)
MSFT   420.72 (-0.17%)
META   485.58 (-1.68%)
GOOGL   150.93 (+0.04%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.14%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
NASDAQ:NEOG

Neogen (NEOG) Stock Price, News & Analysis

$15.78
+0.32 (+2.07%)
(As of 04:38 PM ET)
Today's Range
$15.51
$15.95
50-Day Range
$15.00
$17.64
52-Week Range
$14.44
$24.09
Volume
1.28 million shs
Average Volume
1.88 million shs
Market Capitalization
$3.42 billion
P/E Ratio
263.04
Dividend Yield
N/A
Price Target
$23.50

Neogen MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
48.9% Upside
$23.50 Price Target
Short Interest
Bearish
7.49% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.08mentions of Neogen in the last 14 days
Based on 9 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
35.19%
From $0.54 to $0.73 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.21 out of 5 stars

Medical Sector

610th out of 938 stocks

Diagnostic Substances Industry

6th out of 13 stocks

NEOG stock logo

About Neogen Stock (NASDAQ:NEOG)

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

NEOG Stock Price History

NEOG Stock News Headlines

Neogen: All About Execution From Here On
A lot of people are making this costly mistake
You may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time.
Warning: this could blow your mind
Buckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…
NEOG Jul 2024 30.000 call
NEOG Apr 2024 12.500 call
Neogen Stock Slips 4%
Neogen® Releases SureKill® Gel Bait Pro Applicator
See More Headlines
Receive NEOG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neogen and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
1/09/2024
Today
3/28/2024
Next Earnings (Confirmed)
4/09/2024
Fiscal Year End
5/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostic substances
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:NEOG
CUSIP
64049110
Employees
2,640
Year Founded
1982

Price Target and Rating

Average Stock Price Target
$23.50
High Stock Price Target
$28.00
Low Stock Price Target
$19.00
Potential Upside/Downside
+52.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$-22,870,000.00
Pretax Margin
0.36%

Debt

Sales & Book Value

Annual Sales
$822.45 million
Cash Flow
$0.94 per share
Book Value
$14.49 per share

Miscellaneous

Free Float
214,983,000
Market Cap
$3.35 billion
Optionable
Optionable
Beta
1.14

Social Links

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

NEOG Stock Analysis - Frequently Asked Questions

Should I buy or sell Neogen stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Neogen in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" NEOG shares.
View NEOG analyst ratings
or view top-rated stocks.

What is Neogen's stock price target for 2024?

2 Wall Street analysts have issued 1 year target prices for Neogen's shares. Their NEOG share price targets range from $19.00 to $28.00. On average, they expect the company's stock price to reach $23.50 in the next twelve months. This suggests a possible upside of 48.9% from the stock's current price.
View analysts price targets for NEOG
or view top-rated stocks among Wall Street analysts.

How have NEOG shares performed in 2024?

Neogen's stock was trading at $20.11 at the beginning of 2024. Since then, NEOG shares have decreased by 21.5% and is now trading at $15.78.
View the best growth stocks for 2024 here
.

When is Neogen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 9th 2024.
View our NEOG earnings forecast
.

How can I listen to Neogen's earnings call?

Neogen will be holding an earnings conference call on Tuesday, April 9th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 646-517-4150 with passcode "90261".

How were Neogen's earnings last quarter?

Neogen Co. (NASDAQ:NEOG) announced its quarterly earnings data on Tuesday, January, 9th. The company reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.08. The business had revenue of $229.60 million for the quarter, compared to analysts' expectations of $232.85 million. Neogen had a trailing twelve-month return on equity of 3.35% and a net margin of 1.28%. The company's revenue was down .2% compared to the same quarter last year. During the same period last year, the firm earned $0.15 EPS.

When did Neogen's stock split?

Neogen shares split on the morning of Tuesday, January 2nd 2018. The 4-3 split was announced on Friday, December 8th 2017. The newly minted shares were payable to shareholders after the market closes on Friday, December 29th 2017. An investor that had 100 shares of stock prior to the split would have 133 shares after the split.

What guidance has Neogen issued on next quarter's earnings?

Neogen issued an update on its FY 2024 earnings guidance on Tuesday, January, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $935.0 million-$955.0 million, compared to the consensus revenue estimate of $960.7 million.

What is John Adent's approval rating as Neogen's CEO?

31 employees have rated Neogen Chief Executive Officer John Adent on Glassdoor.com. John Adent has an approval rating of 56% among the company's employees. This puts John Adent in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Neogen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Neogen investors own include NVIDIA (NVDA), NIKE (NKE), Pfizer (PFE), AT&T (T), AbbVie (ABBV), Boeing (BA), JPMorgan Chase & Co. (JPM), W. P. Carey (WPC), Advanced Micro Devices (AMD) and Costco Wholesale (COST).

Who are Neogen's major shareholders?

Neogen's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (9.03%), Vanguard Group Inc. (9.03%), Norges Bank (8.40%), Wasatch Advisors LP (4.32%), Baillie Gifford & Co. (3.83%) and Conestoga Capital Advisors LLC (3.15%). Insiders that own company stock include Darci L Vetter, David H Naemura, Douglas Edward Jones, James P Tobin, Jason Warren Lilly, John Edward Adent, Ronald D Green, Steven J Quinlan, Terri A Morrical and William T Boehm.
View institutional ownership trends
.

How do I buy shares of Neogen?

Shares of NEOG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NEOG) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners